Business and Finance

'Rebates do not raise drug prices, drug makers do,' says the PBM

Trump suggests a ‘streamlined’ FDA will accelerate industry growth

Brand manufacturers retain 47% of net expenditures for drugs

Thumbs up for J&J-Actelion; thumbs down for Aetna-Humana; Walgreens, McKesson actions

Watch for Washington tax policy reform to affect 2017 business

Shorter elapsed time in recent years shows encouraging improvement

Only 20 new molecular entities passed muster this year, less than half of 2015’s total

New consumer-education campaign led by Alliance for Safe Online Pharmacies

A preamble for a next round of legislating drug pricing?

Action is expected to meet FTC objections to the merged chains announced in 2015

Back to square one in addressing high-cost-drug spending

Connecticut leads 20 states suing an alleged ring led by Heritage Pharma

First branded-product discount program from Blink Health

Higher productivity and more complexity; but slow takeup of traceability requirements

Growth rates will moderate in the US and world

Bills passes House with broad bipartisan support; Senate approval likely

A counterargument to the belief that out-of-pocket expenses originate with insurers or PBMs

Sale comes with multi-year supply agreement

Two Canadian Accucaps facilities join global network of 11 Catalent RP Scherer Softgel locations

Allergan’s big commitment to NJ; U. of Michigan converts pharma facilities to healthcare and education

Upcoming trial could explore the intricacies of ‘alternative fulfillment’ via specialty pharmacies

An Amazon-like model for creating an open market for wholesalers to reach customers